Background. In the 1990s, liver transplantations and transjugular intrahepa
tic portosystemic shunts (TIPS) have become the most common methods to deco
mpress portal hypertension. This center has continued to use surgical shunt
s for variceal bleeding in good-risk patients who continue to bleed through
endoscopic and pharmacologic treatment. This article reports this center's
experience with surgical shunts and TIPS shunts from 1992 through 1999.
Methods. Sixty-three patients (Child A, 43 patients; Child B, 20 patients)
received surgical shunts: distal splenorenal, 54 patients; splenocaval, 4 p
atients; coronary caval, 1 patient; and mesocaval, 4 patients. Sixty-two pa
tients had refractory variceal bleeding, and 1 patient had ascites with Bud
d-Chiari syndrome. Two hundred patients (Child A, 24 patients; Child B, 62
patients; Child C, 114 patients) received TIPS shunts. One hundred forty-ni
ne patients had refractory variceal bleeding, and 51 patients had ascites,
hydrothorax, or hepato renal syndrome. Data were collected by prospective d
atabases, protocol follow-up, and phone contact.
Results. The 30-day mortality rate was 0% for surgical shunts and 26% for T
IPS shunts; the overall survival rate was 86% (median follow-up, 36 months)
for surgical shunts and 53% (median following-up, 40 months) for TIPS shun
ts. For surgical shunts, the portal hypertensive rebleeding rate was 6.3%;
the overall rebleeding rate was 14.3%. For TIPS shunts, the overall rebleed
ing rate was 25.5% (30-day, 9.4%; late, 22.4%). There were 4 reintervention
s for surgical shunts (6.3%); the reintervention rate for TIPS shunts in th
e bleeding group was 33%, and the reintervention rate in the ascites group
was 9.5%. Encephalopathy was severe in 3.1% of the shunt group and mild in
17.5%; this was not systematically evaluated in the TIPS shunts patients.
Conclusions. Surgical shunts still have a role for patients whose condition
was classified as Child A and B with refractory bleeding; who achieve exce
llent outcomes with low morbidity and mortality rates. TIPS shunts have bee
n used in high-risk patients with significant early and late mortality rate
s and have been useful in the control of refractory bleeding and as a bridg
e to transplantation. The comparative role of TIPS shunts versus surgical s
hunt in patients whose condition was classified as Child A and B is under s
tudy in a randomized controlled trial.